REG - Acceler8 Ventures - Interim Report
29/09/2025 07:00
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250929:nRSc0705Ba&default-theme=true
RNS Number : 0705B Acceler8 Ventures PLC 29 September 2025
29 September 2025
ACCELER8 VENTURES PLC
Interim Report for the six months ended 30 June 2025
Acceler8 Ventures Plc (LSE: AC8, "AC8" or the "Company") announces its
unaudited condensed interim results for the six month period to 30 June 2025.
Strategy
AC8 was established in 2021 to undertake one or more investment and / or
acquisition opportunities of businesses operating within the UK or
internationally across certain sectors.
The Company retains a flexible investment and acquisition strategy which will,
subject to appropriate levels of due diligence, enable it to deploy capital in
target companies by way of minority or majority investments, or full
acquisitions where it is in the interests of shareholders to do so.
The Company's strategic aim is to drive shareholder value through the
acquisition of target companies in certain sectors where the Board believes
there to be sustainable growth opportunities both organically, and through
acquisition. Sectors of particular focus include gaming, media and
entertainment, software and technology, industrials and business services.
The Company is the parent company of Acceler8 Ventures Subco Limited (a
private limited company under the laws of Jersey with registered number
134587) and together will be referred to as the "Group" in these accounts.
Results and developments in the six month period to 30 June 2025
The Group's loss after taxation was £70,997 (six month period to 30 June
2024: £83,033). This principally reflected operating expenses incurred as a
listed business and due diligence activities of £71,001 (six month period to
30 June 2024: £83,477).
The Group generated a loss per share of £0.09 (six month period to 30 June
2024: £0.11).
As a result of tight cost control and moderate operating expenses, as at 30
June 2025, AC8's cash balance was £1,399 (31 December 2024: £113).
On 18 June 2025, the Company held its Annual General Meeting in which all
resolutions were unanimously passed.
Risks
As the Company has yet to complete an investment or acquisition, it has
limited financial statements and / or historical financial data, and limited
trading history. As such, the Group and Company during the period were subject
to the risks and uncertainties associated with an early-stage acquisition
company.
The Directors are of the opinion that these risks, which were detailed further
in AC8's published final results for the financial year ended 31 December
2024, remain applicable to the Group and Company.
Dividend
At this point in the Company's development, it does not anticipate declaring
any dividends in the foreseeable future. Following the Company's inaugural
investment or acquisition, the Directors will determine an appropriate
dividend policy for AC8.
Outlook
During the period, and post period end, AC8 has continued to pursue its
investment and acquisition strategy and is currently assessing opportunities
within its chosen sectors of interest.
It was disappointing that we were unable to conclude a transaction during the
period, however we are seeing an increased flow of opportunities, which
include successful businesses with the potential for high growth, that are
seeking to partner with, and leverage the benefits of, the Board's experience
and that of the wider AC8 team.
Post the period end, we successfully completed a convertible loan note
issuance raising £0.4 million to support the pursuit of our inaugural
transaction and we are grateful for the support we received, and welcome our
new investors to the Company.
As at 18 September 2025, the Company's current unaudited cash balance was
£0.3 million.
Statement of Directors' responsibilities
The Directors confirm that these condensed interim financial statements have
been prepared in accordance with UK adopted International Accounting Standard
34, 'Interim Financial Reporting' and the Disclosure Guidance and Transparency
Rules sourcebook of the United Kingdom's Financial Conduct Authority and that
the interim management report includes a fair review of the information
required by DTR 4.2.7 and DTR 4.2.8, namely:
· an indication of important events that have occurred during the first six
months and their impact on the condensed set of financial statements, and a
description of the principal risks and uncertainties for the remaining six
months of the financial year; and
· material related-party transactions in the first six months and any material
changes in the related-party transactions described in the last annual report.
By order of the Board
David Williams
Chairman
28 September 2025
Enquiries:
Tessera Investment Management Limited
Tony Morris +44 (0) 7742 189145
INTERIM CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
For the six months ended 30 June 2025
Note Six months ended 30 June 2025 Six months ended 30 June 2024
Unaudited Unaudited
£ £
Administrative expenses (71,001) (83,477)
Operating loss (71,001) (83,477)
Interest receivable 5 4 444
Loss on ordinary activities before taxation (70,997) (83,033)
Taxation charge - -
Loss and total comprehensive loss for the period (70,997) (83,033)
Loss per share
Basic & diluted 10 (£0.09) (£0.11)
Loss attributable to:
Owners of the parent company (70,997) (83,033)
The Group has no items of other comprehensive income in either the current or
prior period. All activities in both the current and the prior period relate
to continuing operations.
The accompanying notes form part of these interim condensed consolidated
financial statements.
INTERIM CONSOLIDATED STATEMENT OF FINANCIAL POSITION
As at 30 June 2025
Note As at As at
30 June 2025 31 December 2024
Unaudited Audited
£ £
Current assets
Cash and cash equivalents 7 1,399 113
Trade and other receivables 8 5,929 7,472
Total current assets 7,328 7,585
Total assets 7,328 7,585
Current liabilities
Trade and other payables 9 124,533 53,949
Total current liabilities 124,533 53,949
Total liabilities 124,533 53,949
Total net liabilities 117,205 46,364
Equity
Share capital 12 7,500 7,500
Share premium 13 729,598 729,598
Capital redemption reserve 13 2 2
Share-based payment reserve 13 1,242 1,086
Non-controlling interest 13 67 67
Retained deficit 13 (855,614) (784,617)
Total equity attributable to equity holders of the Company (117,205) (46,364)
The accompanying notes form part of these interim condensed consolidated
financial statements.
INTERIM CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
For the six months ended 30 June 2024 (Unaudited)
Share capital Share premium Capital redemption reserve Share-based payment reserve Non-controlling interest Retained deficit Total
£ Equity
£ £
£ £ £
£
Balance as at 31 December 2023 7,500 729,598 2 772 67 (624,137) 113,802
Loss for the period - - - - - (83,033) (83,033)
Share-based payment charge - - - 157 - - 157
Balance as at 30 June 2024 7,500 729,598 2 929 67 (707,170) 30,926
For the six months ended 30 June 2025 (Unaudited)
Share capital Share premium Capital redemption reserve Share-based payment reserve Non-controlling interest Retained deficit Total
£ Equity
£ £
£ £ £
£
Balance as at 31 December 2024 7,500 729,598 2 1,086 67 (784,617) (46,364)
Loss for the period - - - - - (70,997) (70,997)
Share-based payment charge - - - 156 - - 156
Balance as at 30 June 2025 7,500 729,598 2 1,242 67 (855,614) (117,205)
The accompanying notes form part of these interim condensed consolidated
financial statements.
INTERIM CONSOLIDATED STATEMENT OF CASH FLOWS
For the six months ended 30 June 2025
Six months ended Six months ended
30 June 2025 30 June 2024
Unaudited Unaudited
£ £
Cash flows from operating activities
Loss before income tax (70,997) (83,033)
Adjustments for:
Share-based payment charge 156 157
Interest receivable (4) (444)
Operating cash flows before changes in working capital (70,845) (83,320)
Increase in trade and other receivables (1,543) (2,170)
Increase / (decrease) in trade and other payables 70,584 (22,596)
Net cash used in operating activities (1,282) (108,086)
Interest received 4 446
Net cash inflow from financing activities 4 446
Net increase / (decrease) in cash and cash equivalents 1,286 (107,640)
Cash and cash equivalents at beginning of period 113 160,441
Cash and cash equivalents at end of period 1,399 52,801
The accompanying notes form part of these interim condensed consolidated
financial statement
NOTES TO THE GROUP FINANCIAL INFORMATION
For the six months ended 30 June 2025
1. General information
The Company is a public limited company incorporated and domiciled in Jersey,
whose shares are publicly traded on the Main Market of the London Stock
Exchange. The Company is the parent company of Acceler8 Ventures Subco Limited
(a private limited company under the laws of Jersey with registered number
134587).
The address of its registered office 28 Esplanade, St. Helier, Channel
Islands, JE2 3QA, Jersey.
The Company has been incorporated for the purpose of identifying suitable
acquisition opportunities in accordance with the Group's investment and
acquisition strategy with a view to creating shareholder value. The Group will
retain a flexible investment and acquisition strategy which will, subject to
appropriate levels of due diligence, enable it to deploy capital in target
companies by way of minority or majority investments, or full acquisitions
where it is in the interests of shareholders to do so. This will include
transactions with target companies located in the UK and internationally.
2. Basis of preparation
These interim condensed consolidated financial statements and accompanying
notes have neither been audited nor reviewed by the Company's auditor.
The unaudited interim financial statements in this report have been prepared
using accounting policies consistent with International Financial Reporting
Standards ("IFRS") as adopted by the UK. The accounting policies adopted in
the interim financial statements are consistent with those adopted in the
Group's last annual report for the year ended 31 December 2024 with regards to
the measurement and recognition of each type of asset, liability, income and
expense presented. The Group has not early adopted any standard,
interpretation or amendment that has been issued but is not yet effective.
The interim condensed consolidated financial statements have been prepared on
a going concern basis.
The interim condensed consolidated financial statements do not include all the
information and disclosures required in the annual financial statements and
should be read in conjunction with the Group's annual report as at 31 December
2024, which is available on the Company's website.
These interim financial statements present selected explanatory notes to
explain events and transactions that are significant to an understanding of
the changes in the Group's financial position and performance since 31
December 2024.
The interim condensed consolidated financial statements are presented in £
and rounded to the nearest £ unless otherwise stated.
These interim condensed consolidated financial statements were approved by the
Board of Directors on 28 September 2025.
Comparative figures
Comparative figures which have been presented cover the six- month period
ended 30 June 2024. The statement of financial position comparative figures
are shown as at 31 December 2024.
Statutory accounts
Financial information contained in this document does not constitute statutory
accounts within the meaning of the Companies (Jersey) Law 1991. The statutory
accounts for the year ended 31 December 2024 have been filed with the
Registrar of Companies. The report of the auditors on those statutory accounts
was unqualified and did not draw attention to any matters by way of emphasis.
3. Significant accounting policies
The interim condensed consolidated financial statements are based on the
following policies which have been consistently applied:
Basis of consolidation
The interim condensed consolidated financial statements present the results of
the Company and its subsidiaries (the "Group") as if they formed a single
entity. Intercompany transactions and balances between Group companies are
therefore eliminated in full.
Where the Group has control over a Company, it is classified as a subsidiary.
The Group controls a company if all three of the following elements are
present: power over the Company, exposure to variable returns from the
Company, and the ability of the Group to use its power to affect those
variable returns. Control is reassessed whenever facts and circumstances
indicate that there may be a change in any of these elements of control.
The interim condensed consolidated financial statements incorporate the
results of business combinations using the acquisition method. In the interim
consolidated statement of financial position, the acquiree's identifiable
assets, liabilities and contingent liabilities are initially recognised at
their fair values at the acquisition date. The acquisition related costs are
included in the consolidated statement of comprehensive income on an accruals
basis. The results of acquired operations are included in the consolidated
statement of comprehensive income from the date on which control is obtained.
Functional and presentational currency
The Group's functional and presentational currency for these financial
statements is the pound sterling.
Interest receivable
Interest receivable is recognised on a time-proportion basis using the
effective interest rate method.
Employee benefits
Short-term employee benefit obligations are measured on an undiscounted basis
and are expensed as the related service is provided. A liability is recognised
for the amount expected to be paid under short-term cash bonus or
profit-sharing plans if the Group has a present legal or constructive
obligation to pay this amount as a result of past service provided by the
employee and the obligation can be estimated reliably.
Cash and cash equivalents
Cash and cash equivalents comprise cash balances and short-term deposits with
an original maturity of three months or less from inception, held for meeting
short term commitments.
Equity
Equity comprises of share capital, share premium, capital redemption reserve,
share based payment reserve, non-controlling interest and retained deficit.
Share capital is measured at the par value.
Share premium and retained deficit represent balances conventionally
attributed to those descriptions. The transaction costs relating to the issue
of shares was deducted from share premium.
The Capital redemption reserve is made up on amounts arising from the
cancellation of the deferred shares.
Share-based payment reserve includes the cumulative share-based payment
charged to equity.
Non-controlling interest reserve arises out of amounts due to holders of the B
shares in Acceler8 Ventures Subco Limited.
Taxation
Tax on the profit or loss for the year comprises current and deferred tax. Tax
is recognised in the income statement except to the extent that it relates to
items recognised in other comprehensive income or directly in equity, in which
case it is recognised in other comprehensive income or equity respectively.
Current tax is the expected tax payable or receivable on the taxable income or
loss for the year, using tax rates and laws enacted or substantively enacted
at the statement of financial position date.
Deferred tax is provided on temporary differences between the carrying amounts
of assets and liabilities for financial reporting purposes and the amounts
used for taxation purposes. The following temporary differences are not
provided for: the initial recognition of goodwill; the initial recognition of
assets or liabilities that affect neither accounting nor taxable profit other
than in a business combination, and differences relating to investments in
subsidiaries to the extent that they will probably not reverse in the
foreseeable future. The amount of deferred tax provided is based on the
expected manner of realisation or settlement of the carrying amount of assets
and liabilities, using tax rates and laws enacted or substantively enacted at
the statement of financial position date.
A deferred tax asset is recognised only to the extent that it is probable that
future taxable profits will be available against which the temporary
difference can be utilised.
Financial assets and liabilities
The Group's financial assets and liabilities comprise of cash and cash
equivalents, other receivables, and trade and other payables. Financial assets
are stated at amortised cost less provision for expected credit losses.
Financial liabilities are stated at amortised cost.
Share-based payments
The Group operates an equity-settled share-based payment plan. The fair value
of the employee services received in exchange for the grant of options is
recognised as an expense over the vesting period, based on the Group's
estimate of awards that will eventually vest, with a corresponding increase in
equity as a share-based payment reserve.
This plan includes market-based vesting conditions for which the fair value at
grant date reflects and are therefore not subsequently revisited. The fair
value is determined using a binomial model.
Related party transactions
The Group discloses transactions with related parties which are not wholly
owned with the same group. It does not disclose transactions with members of
the same group that are wholly owned.
Standards in issue but not yet effective
At the date of authorisation of these financial statements there were
amendments to standards which were in issue, but which were not yet effective,
and which have not been applied. The principal ones were:
· Amendment to IFRS 9 and IFRS 7 - Classification and Measurement of Financial
Instruments (effective for annual periods beginning on or after 1 January
2026)
· IFRS 18 Presentation and Disclosure in Financial Statements (effective for
annual periods beginning on or after 1 January 2027)
· IFRS 19 Subsidiaries without Public Accountability: Disclosures (effective for
annual periods beginning on or after 1 January 2027)
The Directors do not expect the adoption of these amendments to standards to
have a material impact on the financial statements.
4. Critical accounting estimates and judgments
In preparing the interim condensed consolidated financial statements, the
Directors have to make judgments on how to apply the Group's accounting
policies and make estimates about the future. The Directors do not consider
there to be any critical judgments that have been made in arriving at the
amounts recognised in the interim condensed consolidated financial statements.
5. Interest receivable
Six months ended Six months ended
30 June 2025 30 June 2024
Unaudited Unaudited
£ £
Bank interest receivable 4 444
6. Investments
Principal subsidiary undertakings of the Group
The Company directly owns the ordinary share capital of its subsidiary
undertakings as set out below:
Subsidiary Nature of business Country of incorporation Proportion of A ordinary shares held by Company Proportion of B ordinary shares held by Company
Acceler8 Ventures Subco Limited Intermediate holding company Jersey, Channel Islands 100 per cent. 0 per cent.
The address of the registered office of Acceler8 Ventures Subco Limited (the
"Subco") is 28 Esplanade, St. Helier, Channel Islands, JE2 3QA, Jersey. The
Subco was incorporated on 25 March 2021 and prepares its own financial
statements for the period ended 31 March each year.
The A ordinary shares have full voting rights, full rights to participate in a
dividend and full rights to participate in a distribution of capital. The B
ordinary shares have been issued pursuant to the Company's Subco Incentive
Scheme and hold no voting or dividend rights or rights to distribution.
7. Cash and cash equivalents
As at As at
30 June 2025 31 December 2024
Unaudited Audited
£ £
Cash at bank and in hand 1,399 113
8. Trade and other receivables
As at As at
30 June 2025 31 December 2024
Unaudited Audited
£ £
Other receivables 3 3
Prepayments 5,926 7,469
Total 5,959 7,472
9. Trade and other payables
As at As at
30 June 2025 31 December 2024
Unaudited Audited
£ £
Trade creditors 57,310 -
Accruals 51,797 53,949
Director loans 15,426 -
Total 124,533 53,949
10. Earnings per share
Six months ended Six months ended
30 June 2025 30 June 2024
Unaudited Unaudited
£ £
Loss attributable to the equity holders of the Company (70,557) (83,033)
Weighted number of shares in issue 750,000 750,000
Loss per share (£) (0.09) (0.11)
11. Financial instruments
As at As at
30 June 2025 31 December 2024
Unaudited Audited
£ £
Financial assets
Cash and cash equivalents 1,399 113
Other receivables 3 3
1,402 116
As at As at
30 June 2025 31 December 2024
Unaudited Audited
£ £
Financial liabilities
Trade creditors 57,310 -
Accruals 51,797 53,949
Director loans 15,426 -
124,533 53,949
Financial risk management objectives and policies
The Group's financial assets and liabilities comprise of cash and cash
equivalents, other receivables and accruals. The carrying value of all
financial assets and liabilities equals fair value given their short-term
nature.
Credit risk
The Group's credit risk is wholly attributable to its cash balance. All cash
balances are held at a reputable bank in Jersey. The credit risk from its cash
and cash equivalents is deemed to be low due to the nature and size of the
balances held.
Liquidity risk
Liquidity risk is the risk that the Group will not be able to meet its
financial obligations as they fall due.
The Group's approach to liquidity risk is to ensure that sufficient liquidity
is available to meet foreseeable requirements and to invest funds securely and
profitably.
12. Share capital
Allocated, called up and fully paid
As at As at As at As at
30 June 2025 30 June 2025 31 December 2024 31 December 2024
Unaudited Unaudited Audited Audited
Number £ Number £
Ordinary shares of 1p each 750,000 7,500 750,000 7,500
13. Reserves
Share premium and retained deficit represent balances conventionally
attributed to those descriptions. The transaction costs relating to the issue
of shares was deducted from share premium.
The Capital redemption reserve is made up on amounts arising from the
cancellation of the deferred shares.
Share-based payment reserve includes the cumulative share-based payment
charged to equity.
Non-controlling interest reserve arises out of amounts due to holders of the B
shares in Acceler8 Ventures Subco Limited.
The Group having no regulatory capital or similar requirements, its primary
capital management focus is on maximising earnings per share and therefore
shareholder return.
14. Share incentive plan
On 14 July 2021, the Group created a Subco Incentive Scheme within its wholly
owned subsidiary Acceler8 Ventures Subco Limited ("Subco"). Under the terms of
the Subco Incentive Scheme, scheme participants are only rewarded if a
predetermined level of shareholder value is created over a three to five year
period or upon a change of control of the Company or Subco (whichever occurs
first), calculated on a formula basis by reference to the growth in market
capitalisation of the Company, following adjustments for the issue of any new
Ordinary shares and taking into account dividends and capital returns
("Shareholder Value"), realised by the exercise by the beneficiaries of a put
option in respect of their shares in Subco and satisfied either in cash or by
the issue of new ordinary shares at the election of the Company.
Under these arrangements in place, participants are entitled to up to 15 per
cent. of the Shareholder Value created, subject to such Shareholder Value
having increased by at least 12.5 per cent. per annum compounded over a period
of between three and five years from admission or following a change of
control of the Company or Subco.
15. Share-based payments
The Subco Incentive Scheme detailed in Note 14 is an equity-settled share
option plan which allows employees and advisors of the Group to sell their B
shares to the company in exchange for a cash payment or for shares in the
Company (at the Company's election) if certain conditions are met.
These conditions include good and bad leaver provisions and that growth in
Shareholder Value of 12.5 per cent. compound per annual is delivered over a
three to five year period for the scheme to vest. This second condition is
therefore a market condition which has been taken into account in the
measurement at grant date of the fair value of the options.
The weighted average exercise price of the outstanding B share options is
£1.00 which have a weighted average contractual life of 2 years 3 months. No
B share options were issued in the period, all of which were outstanding at
the period end. No B share options were exercised in the period. No B share
options have expired during the period.
The Group recognised £156 (six months ended 30 June 2024: £157) of
expenditure in the statement of total comprehensive income in relation to
equity-settled share-based payments in the period.
The fair value of options granted during the period is determined by applying
a binominal model. The expense is apportioned over the vesting period of the
option and is based on the number which are expected to vest and the fair
value of these options at the date of grant.
The inputs into the binomial model in respect of options granted in the period
are as follows:
Opening share price £1
Expected volatility of share price 16.67%
Expected life of options 5 years
Risk-free rate 0.71%
Target increase in share price per annum 12.5%
Fair value of options 5.397p
Expected volatility was estimated by reference to the average 5-year
volatility of the FTSE SmallCap Index.
The target increase in Shareholder Value is laid out in the Articles of
Association of the Subco and represents the compounded target annual increase
in market capitalisation (adjusted for capital raises and dividends) that
needs to be met between the third and fifth anniversary of the Group's
admission onto the Main Market of the London Stock Exchange in order for the
scheme to vest.
The Group did not enter into any share-based payment transactions with parties
other than employees and advisors during the current period.
16. Related party transactions
Transactions with key management personnel
Key management personnel comprise the directors. The total emoluments for key
management personnel in the period was £20,000 (six months ended 30 June
2024: £20,000). During the period, £20,000 of director fees were accrued
(six months ended 30 June 2024: nil).
Other transactions
During the six months ended 30 June 2025, the directors provided unsecured
loans to the Group of £15,426 (six months ended 30 June 2024: £nil). No
interest is payable by the Group. As at 30 June 2025, the balance
outstanding was £15,426 (as at 30 June 2025: £nil) and is included in trade
and other payables.
17. Contingent liabilities
There are no contingent liabilities at the reporting date which would have a
material impact on the financial statements.
18. Events after the reporting date
On 3 July 2025, trading in the Company's ordinary shares was restored
following the cessation of the proposed acquisition of Verifyyed, Inc., which
was announced on 17 June 2025.
On 29 August 2025, the Group also announced that it had successfully raised
£380,000 through the issue of unsecured Convertible Loan Notes ("CLNs").
The CLN's were issued to new investors to raise funds to support the Company's
modest working capital requirements in pursuit of an initial transaction.
The principal terms of the CLNs are as follows:
Amount: £380,000
Interest rate: 8 per cent. per annum, payable-in-kind and compounding annual
Redemption: no redemption rights applicable save for agreement by the
Noteholder following a tender offer by the Company
Conversion: Automatic conversion of principal and accrued interest on the
earlier of completion of an Initial Transaction (as defined by UKLR 13.4.1)
and the third anniversary of CLN issuance
Conversion price: The lower of £1 per Ordinary Share and a 30 percent.
discount to the prevailing price per Ordinary Share applicable to the Initial
Transaction, or a 30 per cent. discount to a 20-trading day VWAP as at close
on the last trading day prior to the third anniversary of CLN issuance
Security: The CLNs rank pari passu with other unsecured creditors of the
Company
19. Ultimate controlling party
In the opinion of the Directors, there is no single ultimate controlling
party.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END IR UNANRVAUKUARRecent news on Acceler8 Ventures
See all newsREG - Acceler8 Ventures - Interim Report
AnnouncementREG - Acceler8 Ventures - Fundraise
AnnouncementREG - Acceler8 Ventures - Expiration of FCA Transition Provisions
AnnouncementREG - Official List Acceler8 Ventures - Restoration - Acceler8 Ventures PLC
AnnouncementREG - Acceler8 Ventures - Result of AGM
Announcement